Cargando…
Mutation of HIV-1 Genomes in a Clinical Population Treated with the Mutagenic Nucleoside KP1461
The deoxycytidine analog KP1212, and its prodrug KP1461, are prototypes of a new class of antiretroviral drugs designed to increase viral mutation rates, with the goal of eventually causing the collapse of the viral population. Here we present an extensive analysis of viral sequences from HIV-1 infe...
Autores principales: | Mullins, James I., Heath, Laura, Hughes, James P., Kicha, Jessica, Styrchak, Sheila, Wong, Kim G., Rao, Ushnal, Hansen, Alexis, Harris, Kevin S., Laurent, Jean-Pierre, Li, Deyu, Simpson, Jeffrey H., Essigmann, John M., Loeb, Lawrence A., Parkins, Jeffrey |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021505/ https://www.ncbi.nlm.nih.gov/pubmed/21264288 http://dx.doi.org/10.1371/journal.pone.0015135 |
Ejemplares similares
-
Mutations based on viral decay acceleration in the HIV-1 genomes of a clinical population treated with the mutagenic nucleoside KP1461
por: Mullins, James I, et al.
Publicado: (2011) -
The chemistry and biology of KP-1461, a selective nucleoside mutagen for HIV therapy
por: Harris, Kevin, et al.
Publicado: (2006) -
Frequency and signature of somatic variants in 1461 human brain exomes
por: Wei, Wei, et al.
Publicado: (2018) -
1461. Non-Invasive Pneumococcal Pneumonia in the United States, 2013–2014
por: Matanock, Almea, et al.
Publicado: (2018) -
PO-1461 Impact of the COVID-19 pandemic on Radiation Oncology Departments in Brazil
por: Yoshinari Jr, G.H., et al.
Publicado: (2021)